Sign in

CIK 0001374690

  • Non-accelerated filer
  • Smaller reporting company

Larimar Therapeutics, Inc.

Sign in to watch
Ticker
LRMR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
203857670
Phone
+1 844-511-9056
Business address
THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA, 19004
Former names
ZAFGEN, INC., ZAFGEN INC
Open-market buys, last 90 days
$402,143
in 9 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$402,143. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2016-03-31 Secor Alicia Chief Commercial Officer Grant or award · Stock Option (Right to Buy) −53,000 53,000
2016-03-31 Secor Alicia Chief Commercial Officer Grant or award · Stock Option (Right to Buy) −26,500 26,500
2015-09-17 Secor Alicia Chief Commercial Officer Exercise or conversion +25,000 $9.67 $242K 26,256
2015-09-17 Secor Alicia Chief Commercial Officer Sale −25,000 $41.05 $1.0M 1,256
2015-09-17 Secor Alicia Chief Commercial Officer Sale −1,256 $41.05 $52K 0
2015-09-17 Secor Alicia Chief Commercial Officer Exercise or conversion · Stock Option (Right to Buy) −25,000 134,235
2015-02-27 Secor Alicia Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +60,000 219,235
2014-06-19 Secor Alicia Chief Commercial Officer Purchase +4,000 $20.00 $80K 4,000

Page 1 of 1 · 8 trades